CXCL10 and COVID-19: Patients in Cluster 1 primarily comprised subjects with severe COVID-19 who exhibited more clinical signs (Fig. 2F, D) and these subjects presented with higher plasma CRP and chemokine levels, including CXCL10, which is known to be involved in leukocyte trafficking15,16.